EP3889144A1 — Process for preparing glucopyranosyl-substituted benzyl-benzene derivatives
Assigned to Boehringer Ingelheim International GmbH · Expires 2021-10-06 · 5y expired
What this patent protects
The present invention relates to processes for preparing glucopyranosyl-substituted benzylbenzene derivatives of general formula III, wherein R 1 , R 2 and R' are defined according to claim 1; and the use of such processes in the synthesis of SGLT2 inhibitors.
USPTO Abstract
The present invention relates to processes for preparing glucopyranosyl-substituted benzylbenzene derivatives of general formula III, wherein R 1 , R 2 and R' are defined according to claim 1; and the use of such processes in the synthesis of SGLT2 inhibitors.
Drugs covered by this patent
- Jardiance (empagliflozin) · Boehringer Ingelheim
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.